# Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis

> **NCT03713879** · PHASE3 · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 1734 (estimated)

## Conditions studied

- Post ERCP Pancreatitis

## Interventions

- **DEVICE:** pancreatic stenting
- **DRUG:** Indomethacin

## Key facts

- **NCT ID:** NCT03713879
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-21
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 1734 (ESTIMATED)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03713879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03713879, "Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03713879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*